{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:31Z","timestamp":1786985491088,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fund for the Development of Science and Technology","doi-asserted-by":"publisher","award":["0062\/2021\/A"],"award-info":[{"award-number":["0062\/2021\/A"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.brainres.2025.149804","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:57:09Z","timestamp":1750849029000},"page":"149804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An orally administered quinolinium molecule mitigates neuropathology of Alzheimer\u2019s disease through modulation of mitochondrial dysfunction and neuroinflammation"],"prefix":"10.1016","volume":"1863","author":[{"given":"Junqiu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-8524","authenticated-orcid":false,"given":"Kin Yip","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.149804_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood-brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149804_b0010","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41467-024-44818-x","article-title":"Early onset diagnosis in Alzheimer's disease patients via amyloid-beta oligomers-sensing probe in cerebrospinal fluid","volume":"15","author":"An","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2025.149804_b0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer's disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.149804_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031869","article-title":"Molecular mechanisms of neuroinflammation in aging and Alzheimer's disease progression","volume":"24","author":"Andronie-Cioara","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149804_b0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/alz.12683","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis","volume":"19","author":"Ashleigh","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.149804_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-022-00522-2","article-title":"Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease","volume":"17","author":"Bairamian","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainres.2025.149804_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s43587-021-00043-5","article-title":"Healthy aging and the blood-brain barrier","volume":"1","author":"Banks","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.brainres.2025.149804_b0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.brainres.2025.149804_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2019.10.003","article-title":"Neurological disorders and mitochondria","volume":"71","author":"Cabral-Costa","year":"2020","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.brainres.2025.149804_b0050","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.149804_b0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ddr.21631","article-title":"Dual targeting of cholinesterase and amyloid beta with pyridinium\/isoquinolium derivatives","volume":"81","author":"Chakravarty","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.brainres.2025.149804_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.brainres.2025.149804_b0065","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.149804_b0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","article-title":"A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease","volume":"107","author":"Croteau","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.brainres.2025.149804_b0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease","volume":"29","author":"Cunnane","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2025.149804_b0080","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tins.2012.06.004","article-title":"Caspase-3 in the central nervous system: beyond apoptosis","volume":"35","author":"D'Amelio","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2025.149804_b0085","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer's disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2025.149804_b0090","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acssensors.1c00338","article-title":"\u201cTurn-on\u201d quinoline-based fluorescent probe for selective imaging of tau aggregates in Alzheimer's disease: rational design, synthesis, and molecular docking","volume":"6","author":"Elbatrawy","year":"2021","journal-title":"ACS Sens."},{"key":"10.1016\/j.brainres.2025.149804_b0095","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood-brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.brainres.2025.149804_b0100","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2025.149804_b0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.brainres.2025.149804_b0110","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2025.149804_b0115","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2025.149804_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12974-016-0525-7","article-title":"Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease","volume":"13","author":"Heras-Sandoval","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2896\u20132910","key":"10.1016\/j.brainres.2025.149804_b0125","first-page":"e13","article-title":"Mitocytosis, a migrasome-mediated mitochondrial quality-control process","volume":"184","author":"Jiao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2025.149804_b0130","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/acschemneuro.0c00464","article-title":"An isoquinolinium dual inhibitor of cholinesterases and amyloid beta aggregation mitigates neuropathological changes in a triple-transgenic mouse model of Alzheimer's disease","volume":"11","author":"Ju","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.brainres.2025.149804_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108354","article-title":"9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model","volume":"181","author":"Ju","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2025.149804_b0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12035-014-8699-4","article-title":"Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application","volume":"50","author":"Kamat","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2025.149804_b0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jare.2023.12.010","article-title":"Slow gut transit increases the risk of Alzheimer's disease: an integrated study of the bi-national cohort in South Korea and Japan and Alzheimer's disease model mice","volume":"65","author":"Kang","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.brainres.2025.149804_b0150","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2025.149804_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.brainres.2025.149804_b0160","doi-asserted-by":"crossref","unstructured":"Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., Russo, G., Thorton-Wells, T.A., Jones, N., Smith, A.V., Chouraki, V., Thomas, C., Ikram, M.A., Zelenika, D., Vardarajan, B.N., Kamatani, Y., Lin, C.F., Gerrish, A., Schmidt, H., Kunkle, B., Dunstan, M.L., Ruiz, A., Bihoreau, M.T., Choi, S.H., Reitz, C., Pasquier, F., Cruchaga, C., Craig, D., Amin, N., Berr, C., Lopez, O.L., De Jager, P.L., Deramecourt, V., Johnston, J.A., Evans, D., Lovestone, S., Letenneur, L., Moron, F.J., Rubinsztein, D.C., Eiriksdottir, G., Sleegers, K., Goate, A.M., Fievet, N., Huentelman, M.W., Gill, M., Brown, K., Kamboh, M.I., Keller, L., Barberger-Gateau, P., McGuiness, B., Larson, E.B., Green, R., Myers, A.J., Dufouil, C., Todd, S., Wallon, D., Love, S., Rogaeva, E., Gallacher, J., St George-Hyslop, P., Clarimon, J., Lleo, A., Bayer, A., Tsuang, D.W., Yu, L., Tsolaki, M., Bossu, P., Spalletta, G., Proitsi, P., Collinge, J., Sorbi, S., Sanchez-Garcia, F., Fox, N.C., Hardy, J., Deniz Naranjo, M.C., Bosco, P., Clarke, R., Brayne, C., Galimberti, D., Mancuso, M., Matthews, F., European Alzheimer's Disease, I., Genetic, Environmental Risk in Alzheimer's, D., Alzheimer's Disease Genetic, C., Cohorts for, H., Aging Research in Genomic, E., Moebus, S., Mecocci, P., Del Zompo, M., Maier, W., Hampel, H., Pilotto, A., Bullido, M., Panza, F., Caffarra, P., Nacmias, B., Gilbert, J.R., Mayhaus, M., Lannefelt, L., Hakonarson, H., Pichler, S., Carrasquillo, M.M., Ingelsson, M., Beekly, D., Alvarez, V., Zou, F., Valladares, O., Younkin, S.G., Coto, E., Hamilton-Nelson, K.L., Gu, W., Razquin, C., Pastor, P., Mateo, I., Owen, M.J., Faber, K.M., Jonsson, P.V., Combarros, O., O'Donovan, M.C., Cantwell, L.B., Soininen, H., Blacker, D., Mead, S., Mosley, T.H., Jr., Bennett, D.A., Harris, T.B., Fratiglioni, L., Holmes, C., de Bruijn, R.F., Passmore, P., Montine, T.J., Bettens, K., Rotter, J.I., Brice, A., Morgan, K., Foroud, T.M., Kukull, W.A., Hannequin, D., Powell, J.F., Nalls, M.A., Ritchie, K., Lunetta, K.L., Kauwe, J.S., Boerwinkle, E., Riemenschneider, M., Boada, M., Hiltuenen, M., Martin, E.R., Schmidt, R., Rujescu, D., Wang, L.S., Dartigues, J.F., Mayeux, R., Tzourio, C., Hofman, A., Nothen, M.M., Graff, C., Psaty, B.M., Jones, L., Haines, J.L., Holmans, P.A., Lathrop, M., Pericak-Vance, M.A., Launer, L.J., Farrer, L.A., van Duijn, C.M., Van Broeckhoven, C., Moskvina, V., Seshadri, S., Williams, J., Schellenberg, G.D., Amouyel, P., 2013. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 45, 1452-8.","DOI":"10.1038\/ng.2802"},{"key":"10.1016\/j.brainres.2025.149804_b0165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11030-024-10927-4","article-title":"Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer's agents: design, synthesis and biological evaluation","volume":"29","author":"Nagani","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.brainres.2025.149804_b0170","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1002\/alz.14282","article-title":"Brexpiprazole treatment for agitation in Alzheimer's dementia: a randomized study","volume":"20","author":"Nakamura","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2025.149804_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127392","article-title":"Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3beta level targeting Alzheimer's disease","volume":"253","author":"Noori","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.brainres.2025.149804_b0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2025.149804_b0185","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1523\/JNEUROSCI.1583-16.2016","article-title":"Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function","volume":"36","author":"Pan","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149804_b0190","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10715760902751902","article-title":"Involvement of ROS in BBB dysfunction","volume":"43","author":"Pun","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.brainres.2025.149804_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102291","article-title":"Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies\/systems","volume":"97","author":"Roghani","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.brainres.2025.149804_b0200","article-title":"Exploring novel quinoline-1,3,4-oxadiazole derivatives for Alzheimer's disease: their design, synthesis, and in-vitro and in-silico investigations","author":"Saffour","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.brainres.2025.149804_b0205","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2025.149804_b0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-food-111317-095850","article-title":"Omega-3 polyunsaturated fatty acids and their health benefits","volume":"9","author":"Shahidi","year":"2018","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.brainres.2025.149804_b0215","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2025.149804_b0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2025.149804_b0225","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jnutbio.2009.11.003","article-title":"Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance","volume":"21","author":"Su","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.brainres.2025.149804_b0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2025.149804_b0235","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/glia.23024","article-title":"Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer's disease","volume":"64","author":"Tischer","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2025.149804_b0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2025.149804_b0245","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41380-022-01912-0","article-title":"Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease","volume":"28","author":"Varma","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2025.149804_b0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tig.2018.02.007","article-title":"Understanding Alzheimer disease at the interface between genetics and transcriptomics","volume":"34","author":"Verheijen","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.brainres.2025.149804_b0255","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","article-title":"Gut microbiome alterations in Alzheimer's disease","volume":"7","author":"Vogt","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2025.149804_b0260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.brainres.2025.149804_b0265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.brainres.2025.149804_b0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2018.01.003","article-title":"SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease","volume":"131","author":"Wu","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2025.149804_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.852433","article-title":"DHA ameliorates cognitive ability, reduces amyloid deposition, and nerve fiber production in Alzheimer's disease","volume":"9","author":"Xiao","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.brainres.2025.149804_b0280","article-title":"The impact of systemic inflammation on Alzheimer's disease pathology","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2025.149804_b0285","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","article-title":"Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application","volume":"12","author":"Xu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.brainres.2025.149804_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.120381","article-title":"Evaluation of whole-brain oxygen metabolism in Alzheimer's disease using QSM and quantitative BOLD","volume":"282","author":"Yang","year":"2023","journal-title":"Neuroimage"},{"key":"10.1016\/j.brainres.2025.149804_b0295","doi-asserted-by":"crossref","DOI":"10.1177\/23337214231159759","article-title":"Alzheimer's disease is a disorder of consciousness","volume":"9","author":"Yokoi","year":"2023","journal-title":"Gerontol Geriatr Med."},{"key":"10.1016\/j.brainres.2025.149804_b0300","first-page":"26","article-title":"Hybrid quinoline-thiosemicarbazone therapeutics as a new treatment opportunity for Alzheimer's disease\u2013synthesis, in vitro cholinesterase inhibitory potential and computational modeling analysis","author":"Zaib","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2025.149804_b0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12979-024-00445-0","article-title":"Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells","volume":"21","author":"Zhang","year":"2024","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.brainres.2025.149804_b0310","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.brainres.2025.149804_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101483","article-title":"Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease","volume":"72","author":"Zhao","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.brainres.2025.149804_b0320","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4155\/bio-2015-0014","article-title":"Quantification of permanent positively charged compounds in plasma using one-step dilution to reduce matrix effect in MS","volume":"8","author":"Zhou","year":"2016","journal-title":"Bioanalysis"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325003658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325003658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:11:55Z","timestamp":1779700315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325003658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"alternative-id":["S0006899325003658"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149804","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An orally administered quinolinium molecule mitigates neuropathology of Alzheimer\u2019s disease through modulation of mitochondrial dysfunction and neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149804"}}